Skip to main content

Placental Malperfusion

  • Chapter
  • First Online:
Manual of Pathology of the Human Placenta

Abstract

Placental insufficiency is a term often used in connection with placental malperfusion and is sometimes defined as a critical reduction of the placental exchange membrane. It is a most difficult term to define precisely. Ratios of placental to fetal weight have been used to correlate with placental function, but alterations of this ratio are so frequent that one cannot deduce placental dysfunction from an abnormal ratio (see Table 3.7 in Chap. 3). “Placental insufficiency” may be due to a variety of factors including abnormal fetal genome, chronic infection, maternal disease, localization of the placenta in the uterus, cord insertion, preeclamptic changes, chorangiosis, tumors, fetal thrombotic vasculopathy, excessive fibrinoid deposits, and so on. We prefer to specify the lesions that are present rather than to embrace them all in the imprecise terminology of “placental insufficiency.” Placental malperfusion, on the other hand, also has many synonyms, including placental underperfusion, uteroplacental malperfusion, uteroplacental underperfusion, and ­placental bed underperfusion. These all describe the same thing and have in common a number of features, with the primary defect being an abnormality in uteroplacental vessels. These abnormalities and their sequelae are described below.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Selected References

  • PHP5, pages 155–165 (Oxygen and Oxygen-Controlled Growth Factors as Regulators of Villous and Vascular development), 249–261 (Uteroplacental Vessels), 473–490 (Histopathologic Approach to Villous Alterations), 491–518 (Classification of Villous Maldevelopment), 604–656 (Maternal Diseases Complicating Pregnancy: Preeclampsia, Lupus Erythematosus and Lupus Anticoagulant).

    Google Scholar 

  • Baergen RN, Chacko SA, Edersheim T, et al. The placenta in thrombophilias: a clinicopathologic study. Mod Pathol 2001;14:213A.

    Article  Google Scholar 

  • Infante-Rivard C, David M, Gauthier R, et al. Lupus anticoagulants, anticardiolipin antibodies and fetal loss. A case-control study. N Engl J Med 1991;325:1063–1066.

    Article  CAS  PubMed  Google Scholar 

  • Khong TY, Pearce JM, Robertson WB. Acute atherosis in preeclampsia: Maternal determinants and fetal outcome in the presence of the lesion. Am J Obstetr Gynecol 1987;157:360–363.

    CAS  Google Scholar 

  • Kingdom JCP, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997;18:613–621.

    Article  CAS  PubMed  Google Scholar 

  • Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9–13.

    Article  CAS  PubMed  Google Scholar 

  • Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346(10):752–763.

    Article  CAS  PubMed  Google Scholar 

  • Magid MS, Kaplan C, Sammaritano LR, et al. Placental pathology in systemic lupus erythematosus: A prospective study. Am J Obstet Gynecol 1998;179:226–234.

    Article  CAS  PubMed  Google Scholar 

  • Rand JH, Wu XX, Andree HAM, et al. Pregnancy loss in the antiphospholipid-antibody syndrome – a possible thrombogenic mechanism. N Engl J Med 1997;337:154–160.

    Article  CAS  PubMed  Google Scholar 

  • Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901–908.

    Article  PubMed  Google Scholar 

  • Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967;93:581–592.

    Article  CAS  PubMed  Google Scholar 

  • Tenney B, Parker F. The placenta in toxemia of pregnancy. Am J Obstetr Gynecol 1940;39:1000–1005.

    Google Scholar 

  • Van Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of placentas and abortion specimens from women with anti-phospholipid and antiphospholipid-like syndrome. Placenta 2004;25:642–648.

    Article  PubMed  Google Scholar 

  • Yoon BH, Lee CM, Kim SW. An abnormal umbilical artery waveform: A strong and independent predictor of adverse perinatal outcome in patients with preeclampsia. Am J Obstet Gynecol 1994;171:713–721.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Baergen, R.N. (2011). Placental Malperfusion. In: Manual of Pathology of the Human Placenta. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7494-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7494-5_18

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-7493-8

  • Online ISBN: 978-1-4419-7494-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics